Relationship Between Genes Important in Blood Pressure Regulation and Blood Pressure Therapy in Hypertension
NCT02524873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99
Last updated 2017-03-21
Summary
Whether patients with a functional genotype of a protein important in blood pressure regulation respond better to a drug therapy class/combination of therapy classes that target that specific pathway using the Geneticure panel for high blood pressure
Conditions
Interventions
- DEVICE
-
Geneticure Collection Kit for Pharmaocogenetics of Hypertension
Buccal (cheek) swab kit for DNA collection for analysis of genes for hypertension
Sponsors & Collaborators
-
Geneticure, LLC
lead INDUSTRY
Principal Investigators
-
Krista Kleve · RCRI
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
More Related Trials
-
Genetic Epidemiology of Blood Pressure Intervention
NCT00079690 ·Status: COMPLETED
-
Pharmacogenetic Prediction of Metoprolol Effectiveness
NCT02293096 ·Status: TERMINATED ·Phase: NA
-
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
NCT01658657 ·Status: COMPLETED ·Phase: NA
-
Genetic Mechanisms in Human Hypertension Renin-angiotensin-aldosterone System (RAAS) Inhibition Study
NCT01009944 ·Status: WITHDRAWN ·Phase: NA
-
Genetic and Environmental Determinants of Hypertension
NCT00005149 ·Status: COMPLETED
-
Childhood-Onset Essential Hypertension Natural History Study
NCT06778239 ·Status: RECRUITING
-
The Effect of Sodium Nitrite on Renal Function and Blood Pressure in Hypertensive Versus Healthy Subjects
NCT02527837 ·Status: UNKNOWN ·Phase: PHASE1
-
Genetic Architecture of Natriuretic Peptides and Blood Pressure Response
NCT07118592 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
NCT04060641 ·Status: UNKNOWN
-
Angiotensinogen Gene and Human Hypertension
NCT00063492 ·Status: COMPLETED
-
Analyzing Genetic Factors Involved in Blood Pressure Changes Due to Salt and Potassium Intake (The GenSalt Study)
NCT00721721 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacogenomic Evaluation of Antihypertensive Responses
NCT00246519 ·Status: COMPLETED ·Phase: PHASE4
-
Longitudinal Follow-up Study in Two Chinese Hypertension Cohorts
NCT04471389 ·Status: UNKNOWN
-
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
NCT02245230 ·Status: TERMINATED ·Phase: PHASE1
-
Novel Evaluation With QGC001 in Hypertensive Overweight Patients of Multiple Ethnic Origins
NCT03198793 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
NCT00681278 ·Status: COMPLETED
-
The Natriuretic Peptide System in African-Americans.
NCT02730780 ·Status: COMPLETED ·Phase: NA
-
Genetic Determinant of Blood Pressure Sensitivity to Salt Intake
NCT01706887 ·Status: TERMINATED ·Phase: NA
-
Correlates and Control of Blood Pressure Variability
NCT06012487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension
NCT02322450 ·Status: COMPLETED ·Phase: PHASE2
-
L-Arginine Metabolism in Essential Hypertension
NCT00137124 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Feasibility Study of the Intensive Systolic Blood Pressure Control
NCT02817503 ·Status: UNKNOWN ·Phase: PHASE4
-
Study 2: Effect of Minocycline Treatment on Drug-Resistant Hypertensive Patients
NCT02133885 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Targeting Endoplasmic Reticulum Stress in Human Hypertension
NCT06025630 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
NCT00380289 ·Status: UNKNOWN ·Phase: NA